TherapeuticsMD (NASDAQ:TXMD – Get Free Report) and Shineco (NASDAQ:SISI – Get Free Report) are both small-cap healthcare companies, but which is the superior stock? We will compare the two businesses based on the strength of their institutional ownership, valuation, risk, profitability, dividends, earnings and analyst recommendations.
Earnings and Valuation
This table compares TherapeuticsMD and Shineco”s revenue, earnings per share and valuation.
| Gross Revenue | Price/Sales Ratio | Net Income | Earnings Per Share | Price/Earnings Ratio | |
| TherapeuticsMD | $3.02 million | 7.74 | -$570,000.00 | $0.02 | 101.00 |
| Shineco | $9.60 million | 0.00 | -$22.45 million | ($204.00) | -0.00 |
Risk & Volatility
TherapeuticsMD has a beta of 0.65, indicating that its share price is 35% less volatile than the S&P 500. Comparatively, Shineco has a beta of -1.76, indicating that its share price is 276% less volatile than the S&P 500.
Profitability
This table compares TherapeuticsMD and Shineco’s net margins, return on equity and return on assets.
| Net Margins | Return on Equity | Return on Assets | |
| TherapeuticsMD | -6.64% | -1.09% | -0.78% |
| Shineco | -380.55% | -79.89% | -33.01% |
Analyst Recommendations
This is a breakdown of recent ratings and price targets for TherapeuticsMD and Shineco, as reported by MarketBeat.com.
| Sell Ratings | Hold Ratings | Buy Ratings | Strong Buy Ratings | Rating Score | |
| TherapeuticsMD | 1 | 0 | 0 | 0 | 1.00 |
| Shineco | 1 | 0 | 0 | 0 | 1.00 |
Insider and Institutional Ownership
30.7% of TherapeuticsMD shares are owned by institutional investors. Comparatively, 4.1% of Shineco shares are owned by institutional investors. 1.7% of TherapeuticsMD shares are owned by insiders. Comparatively, 0.0% of Shineco shares are owned by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company is poised for long-term growth.
Summary
TherapeuticsMD beats Shineco on 10 of the 11 factors compared between the two stocks.
About TherapeuticsMD
TherapeuticsMD, Inc. operates as a pharmaceutical royalty company in the United States. It has a license agreement with Mayne Pharma to commercialize the IMVEXXY, BIJUVA, and ANNOVERA prescription prenatal vitamin products sold under the BocaGreenMD and vitaMedMD brand names. The company sells its prescription pharmaceutical products and prenatal vitamin products through wholesale distributors and retail pharmacy distributors. TherapeuticsMD, Inc. was founded in 2008 and is headquartered in Boca Raton, Florida.
About Shineco
Shineco, Inc., through its subsidiaries, processes and distributes agricultural produce. It also engages in the growing and cultivation of mulberry trees and silkworm cocoons; distribution of fruit business; and processing and distribution of silk and silk fabrics, as well as other by-products. The company was incorporated in 1997 and is headquartered in Beijing, the People's Republic of China.
Receive News & Ratings for TherapeuticsMD Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for TherapeuticsMD and related companies with MarketBeat.com's FREE daily email newsletter.
